South Korean Pharmaceuticals & Biotech Most Popular Stocks

Femtobiomed

Market Cap: ₩38.8b

Engages in the development of cargo-free intracellular delivery platform.

Quratis

Market Cap: ₩38.6b

Engages in developing vaccines in South Korea.

Seoul Pharma

Market Cap: ₩38.4b

Manufactures and sells pharmaceutical products in South Korea and internationally.

MFC

Market Cap: ₩36.2b

Operates as a pharmaceutical company in South Korea.

Daesung Microbiological Labs

Market Cap: ₩35.1b

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.

Kainos Medicine

Market Cap: ₩35.0b

Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.

ChoA Pharmaceutical

Market Cap: ₩34.4b

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.

NGeneBio

Market Cap: ₩34.1b

Develops in vitro diagnostics companion diagnostics products and bioinformatics software.

Green Lifescience

Market Cap: ₩33.5b

Engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally.

HLB SCIENCE

Market Cap: ₩32.9b

Develops biological drugs with MoA to infectious diseases.

Curachem

Market Cap: ₩29.5b

Provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development.

Baskhanbio Pharma

Market Cap: ₩30.5b

Provides pain medicines before and after surgery, and medical devices for surgical process in South Korea.

GeneBioTech Ltd

Market Cap: ₩27.9b

Engages in the manufacture and sale of feed additives and functional food in South Korea.

Aptamer Sciences

Market Cap: ₩27.5b

A bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.

Epibiotech

Market Cap: ₩27.3b

A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.

WOOJUNG BIO

Market Cap: ₩25.9b

Provides non-clinical research agency services.

WooGene B&G

Market Cap: ₩25.6b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

Celemics

Market Cap: ₩24.8b

Designs, manufactures, and distributes sequencing kits in South Korea.

Clinomics

Market Cap: ₩24.6b

A biotechnology company, provides genome-based cancer and disease diagnostic solutions.

SCM Lifescience

Market Cap: ₩24.2b

Operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses.

BioInfra

Market Cap: ₩24.2b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

Median Diagnostics

Market Cap: ₩23.6b

Develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals.

Moogene Medi

Market Cap: ₩23.0b

Develops gene therapies based on its proprietary gene-editing platform technology.

Plumbline Life Sciences

Market Cap: ₩22.9b

Engages in the development and sale of DNA medicines for animals.

SLS BIO

Market Cap: ₩22.2b

Develops diagnostic technologies in South Korea.

Angiolab

Market Cap: ₩22.1b

A biotechnology company, develops medicine with angiogenesis inhibitors for treating angiogenesis-related diseases.

NeoImmuneTech

Market Cap: ₩21.4b

A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

ADBiotech

Market Cap: ₩17.0b

Develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally.

Union Korea Pharm

Market Cap: ₩15.4b

Engages in the research, development, production, and sale of prescription drugs in South Korea.

OLIPASS

Market Cap: ₩11.1b

A biotech company, focuses on developing therapeutic products in South Korea.

Apures

Market Cap: ₩8.2b

Engages in the development and commercialization of solutions for the bio and medical industries in South Korea.

BioInfra Life Science

Market Cap: ₩8.1b

BIOINFRA Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.

Genotech

Market Cap: ₩7.8b

Provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally.

Future Medicine

Market Cap: ₩7.5b

Operates as a drug development company worldwide.

MEDIZEN HUMANCARE

Market Cap: ₩6.2b

A research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally.

TechnologyLtd

Market Cap: ₩5.8b

Manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea.